ASH: Late Effects Uncommon for Patients With Sickle Cell Disease After Allogeneic HCT

WEDNESDAY, Dec. 10, 2025-- Late effects are rare for patients with sickle cell disease (SCD) undergoing allogeneic hematopoietic cell transplantation (HCT), according to a study presented at the annual meeting of the American Society of...